Skip to content

Comparative study between contrast enhanced mammography and breast MRI in local pre-operative staging of invasive lobular carcinoma: A cross-sectional study.

2026 · Clinica Terapeutica · Vol 177 5, pp. 1201-1207 · 0 citations
Medicine

TL;DR

MRI provides superior accuracy in assessing tumor size and disease extent and remains the preferred staging modality, however, CEM offers excellent performance in evaluating multifocality, multicentricity, and laterality, making it a valuable alternative when MRI is unavailable or contraindicated.

View source

Similar papers

Open access Sep 2026

Pathologic complete response and residual disease after neoadjuvant chemotherapy in breast cancer: Comparison of contrast-enhanced mammography, DCE-MRI, and ¹⁸F-FDG PET/CT.

Accurate assessment of breast cancer response to neoadjuvant chemotherapy (NAC) is important for surgical planning. We compared contrast-enhanced mammography (CEM), dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FD...

Ebru Özan Sanhal, İmren Mutlu, Evrim Sürer Budak et al. · 0 citations
Open access Sep 2026

Evaluating Depth of Invasion in Tongue Carcinoma: Correlation of Intraoral Ultrasound and Magnetic Resonance Imaging and With Histopathological Findings.

BACKGROUND Tongue carcinoma requires accurate preoperative assessment of depth of invasion (DOI) for optimal management and prognostication. The 8th AJCC/UICC TNM staging system recognizes DOI as a key determinant of T-stage, risk of nodal metastases, and survival. Magnetic Resonance imaging (MRI) offers excellent soft...

Anamika Das, Jyoti Kumar, Swezal Lohia et al. · 0 citations
Open access Sep 2026

Breast DCE-MRI morphological features and semi-quantitative parameters associated with upgrade to invasive carcinoma in biopsyproven DCIS

Abstract Background The aim of this study was to identify imaging predictors of upgrade to invasive carcinoma (IC) in patients with biopsy-proven ductal carcinoma in situ (DCIS) based on morphological features and semi-quantitative parameters derived from dynamic contrast-enhanced breast magnetic resonance imaging (DCE...

V. Urban, Z. Milosevic, Z. Bukumirić et al. · 0 citations
Review Open access Sep 2026

Whole-body MRI for the evaluation of metastatic lobular breast cancer; current uses and future directions

Invasive lobular cancer (ILC) metastases are harder to detect radiologically than metastases from invasive breast cancer of no specific type (IBC-NST) due to a unique tumour biology. Metastatic ILC (mILC) spread is also unusual and challenging, favouring sites such as the peritoneum. The sclerotic bone metastases com...

K. Downey, B. Bhaludin, N. Tunariu et al. · 0 citations
Sep 2026

Performance of Photon-counting CT for Assessing Pretreatment Breast Cancer: Comparison with Mammography, MRI, and 18F-FDG PET/CT.

Background Photon-counting CT (PCCT) offers improved spatial resolution, contrast to noise ratio, and dose efficiency, but its clinical utility remains incompletely defined for breast cancer. Purpose To evaluate the feasibility of PCCT for pretreatment breast cancer assessment through comparisons with MRI, full-field d...

Qiu-Yi Fu, Yu-Fei Zeng, Rui Chang et al. · 1 citation
Open access Sep 2026

DCE-MRI and Mammography integrated radiomic analysis in triple negative ductal invasive breast cancer patients. Comparison between BRCA and not BRCA mutated patients: preliminary results

A combined radiomic model based on features extracted from DCE-MRI and mammographic images to discriminate the mutational status of BRCA genes in patients with TNBC reinforces the feasibility of radiomics to predict BRCA mutation in patients with TNBC.

A. Pecchi, Cecilia Beretta, Erica Balboni et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.